Filter
1510
Filtered Results: 1510
Text search:
pharmaceutical
situation
Featured
Recommendations
150
New Publications
407
Language
Document type
No document type
801
Studies & Reports
272
Guidelines
234
Strategic & Response Plan
71
Manuals
63
Fact sheets
22
Training Material
19
Situation Updates
17
Resource Platforms
5
Infographics
4
Brochures
2
Countries / Regions
Ethiopia
69
Kenya
63
India
58
Global
42
South Africa
39
Western and Central Europe
38
Nigeria
35
Sierra Leone
34
Uganda
33
Liberia
30
Ghana
27
Tanzania
24
Ukraine
20
Malawi
20
Namibia
20
Nepal
19
Rwanda
18
Latin America and the Carribbean
18
Bangladesh
18
Zambia
18
Philippines
17
Africa
17
Syria
16
Eastern Europe
15
South–East Asia Region
14
Cambodia
13
Congo, Democratic Republic of
13
Lesotho
12
Indonesia
12
Zimbabwe
11
Germany
11
Myanmar / Burma
11
Cameroon
8
Venezuela
7
West and Central Africa
7
Eastern Europe and Central Asia
7
Botswana
7
South Sudan
7
Thailand
6
Senegal
6
Asia
6
Albania
5
Burkina Faso
5
Guinea
5
Haiti
5
Vietnam
5
Eswatini/ Swaziland
5
Benin
4
China
4
Chile
4
Laos
4
Middle East and North Africa
4
Western Pacific Region
4
East and Southern Africa
4
Papua New Guinea
4
Pakistan
4
Fiji
3
Mozambique
3
Jordan
3
Brazil
3
Egypt
3
Sudan
3
Mali
3
North Macedonia
2
Peru
2
USA
2
Lithuania
2
Jamaica
2
Lebanon
2
Moldova
2
Russia
2
Central African Republic
2
Iraq
2
Madagascar
2
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
Serbia
1
Iran
1
Kyrgyzstan
1
Niger
1
Afghanistan
1
Bulgaria
1
Ireland
1
Paraguay
1
North America
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
France
1
Maldives
1
United Kingdom
1
Spain
1
Argentina
1
Yemen
1
Romania
1
Palestine
1
Georgia
1
Chad
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
657
Key Resources
88
Clinical Guidelines
87
Public Health
68
Women & Child Health
37
Pharmacy & Technologies
18
Capacity Building
13
Annual Report MEDBOX
2
Toolboxes
AMR
158
COVID-19
153
Pharmacy
103
Mental Health
95
TB
67
HIV
55
Rapid Response
50
NTDs
37
Conflict
33
Planetary Health
31
Ebola & Marburg
30
Global Health Education
29
Caregiver
27
NCDs
23
Health Financing Toolbox
20
Specific Hazards
11
Natural Hazards
9
Polio
9
Refugee
8
Disability
7
Cholera
3
Zika
3
South Sudan
1
Social Ethics
1
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptio...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arlington, VA: JSI Research & Training Institute, Inc....
A WHO-UNICEF joint statement encouraging greater health commodity supply chain integration for temperature-sensitive pharmaceuticals where appropriate, 19 November 2020
This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated in 2016. This strategy provides a regulatory and imp...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
Social distancing is an action taken to minimise contact with other individuals; social distancing measures comprise one category of non-pharmaceutical countermeasures (NPCs)1 aimed at reducing disease transmission and thereby also reducing pressure on health services.
This document builds upon exi...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
Soumis à l’Agence des États-Unis pour le développement international par le programme SIAPS (Systems for Improved Access to Pharmaceuticals and Services ou Programme des systèmes pour l’amélioration de l’accès aux produits et services pharmaceutiques). Arlington, VA : Management Sciences...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
Contact tracing is a key component of the COVID-19 response, particularly as societies begin to lift non-pharmaceutical interventions. However, it is a time-consuming and resource-intensive effort that depends on a trained and motivated workforce. Emergent digital contact tracing and quarantine (...
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to...
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
